NATURAL PRODUCTS
Ma-Huang (Ephedra sinica)
Ma-Huang is used to help with cough, bronchitis,
asthma, and as a stimulant to help stay awake. Several well known companies are
marketing and promoting ephedrine from natural sources, under various enticing brand
names, as an aid in weight loss by increasing metabolism. It has been called Natural
Fen-Phen and Herbal Ecstasy. Prescription ephedrine has been used to treat asthma
and its potent CNS stimulatory effects were used to treat narcolepsy, but its use has been
limited, due to side effects and safer alternatives. Ephedrine was one of the
ingredients in the prescription drug, Marax, in which it was used as a bronchodilator in
the treatment of asthma. Ma-Huang contains multiple isomers of ephedrine, including
pseudoephedrine, norpseudoephedrine, and norephedrine, which are all sympathomimetic
stimulants. Consequently, Ma-Huang can increase blood pressure and cardiac output,
which can be dangerous in people with hypertension or cardiac disease. Caution
should be exercised with Ma-Huang products, due to purity and safety issues. In some
cases, actual dosages may not be what is reflected on the label.
The FDA has approved phenylpropanolamine, not
ephedrine, for use as an appetite suppressant in both prescription and over-the-counter
(OTC) drugs. It causes less CNS stimulation than ephedrine, but otherwise is
approximately equal in potency to ephedrine. The chemical structure of
phenylpropanolamine is quite similar to that of ephedrine. As for the use of
ephedrine preparations as an aid in weight loss programs, if one looks at controlled
studies of its prescription counterparts, long term weight loss effects require it to be
taken continuously. Additionally, as with other weight loss products, its
effectiveness is enhanced by a solid exercise program and dietary modifications.
Ephedrine preparations for weight loss are not magic
bullets. They work primarily as appetite suppressants and significantly less as
metabolic stimulants, even though they are marketed as having a "thermogenic
effect."
Taking ephedrine-based weight loss preparations with
other ephedrine containing products, to help stay awake while driving, can significantly
worsen the side effects seen. Such combinations should be avoided and can be
dangerous. Likewise, taking ma huang with other products containing
sympathomimetics, such as pseudoephedrine may result in an increase in adverse reactions.
Ma Huang is contraindicated in hypertension, closed
angle glaucoma, pheochromocytoma, thyrotoxicosis, cerebral vascular disease, cardiac
disease, and pregnancy. Drug interactions include digoxin; antihypertensives,
including beta blockers, alpha blockers, and guanethidine related products; oxytocin (used
in obstetrics to increase uterine contractions); monoamine oxidase inhibitors (MAOI) for
depression, like Parnate and Nardil; and phenothiazine drugs. Ma Huang use should be
avoided by anybody taking these drugs. There should be at least a 2 week period
between stopping an MAOI drug like Parnate and starting Ma Huang, to prevent severe
increases in blood pressure. Ma Huang should also be avoided by people taking
tricyclic antidepressants, because it can lead to a further increase in blood pressure.
Consider ma huang very dangerous in any of these conditions.
Ephedrine is excreted in the urine. Ordinarily
this wouldn't be a problem, but in people with impaired renal (kidney) function, the
metabolites are not cleared from the body as well as in a person with normal renal
function. People with kidney disease should discuss the use of Ma Huang and its
recommended dosage with their physician prior to using it.
Studies have shown that ephedrine can cause urinary
retention, especially in men with benign prostatic hypertrophy. Ma Huang should be
avoided in such cases. Men using saw palmetto to treat benign prostatic hypertrophy
and taking Ma Huang may find that the saw palmetto is less effective or may no longer
work.
Unlike several other catecholamine sympathomimetics,
ephedrine is not metabolized by catechol- O-methyl-transferase (COMT) and monoamine
oxidase, the primary enzymes responsible for metabolizing such molecules. Thus it
has a significantly longer duration of action. Complicating things further is that
tachyphylaxis (a rapidly decreasing response to the drug after only a few doses) can occur
with ephedrine. Increasing the dose, in such cases, to get the desired effect may be
unsafe and should be avoided.
A single adult dose of ephedrine alkaloid of 15 - 30
mg with a maximum of 300 mg per day is reported in the literature. Most dietary
supplement manufacturers are recommending a maximum daily ephedrine alkaloid consumption
of no more than 100 mg and no more than 25 mg per serving or dose. Product labeling
may be of no value, because some products do not provide the amount to take or list any
safety warnings. According to the FDA, Ma Huang doses should be separated by at
least 6 hours, due to the duration of action of each dose and to prevent accumulation of
ephedrine in the body. The percentage of ephedrine in Ma Huang preparations varies,
but many manufacturers report approximately 6% of the herbal extract contains ephedrine.
If one was to assume this to be correct, a marketed serving size containing 320 mg
Ma Huang would contain 19.2 mg ephedrine, as well as a percentage of pseudoephedrine and
other variants as mentioned earlier. At issue here is that the FDA has been
monitoring and assessing the number of adverse reactions, due to herbal ephedrine
preparations, and has been trying to address the problem with labeling changes and serving
size limitations.
The FDA is recommending ephedrine intake be limited
to no more than 8 mg in a 6 hour period and not to exceed 24 mg per day, in order to
decrease the number of adverse reactions. And the FDA has recommended ephedrine use
be limited to 7 days or less. Such a short term use would preclude ephedrine use as
a diet aid. The FDA currently limits ephedrine in pharmaceuticals to not exceed 150
mg per day. The FDA is currently reviewing ephedrine in dietary supplements and has
retracted their dietary supplement limitations pending further review.
When taken appropriately, Ma Huang may provide an
alternative to other treatment options in some people, but due to safety concerns, it may
be best to avoid it. Dosing may prove difficult, because depending on the
quality of the preparation and patient variability, the amount of Ma-Huang that must be
taken to reach an effective single adult dose is quite variable. In addition,
some preparations contain vitamins and other stimulants, such as caffeine.
Combinations of ephedrine with other stimulants will result in an enhanced effect and an
increase in adverse reactions. Such combination products may be unsafe.
Some truck stops and travel plazas sell several
different ephedrine alkaloid products to help drivers stay awake. Labeled doses have
ranged up to 325 mg per capsule or tablet. The Federal Government is trying to
control the sale of ephedrine because it can be used in the manufacture of
methamphetamine. In California and other states, ephedrine cannot be sold to anyone
younger than 18 years old and the quantity sold cannot exceed 9 grams per
transaction. Violations are a misdemeanor.
Copyright 2000 Solumedia. All rights reserved. This information
may not be duplicated or transmitted in any manner without the express written permission
of Solumedia.
Legal Info: Solumedia
is not responsible for errors or omissions. The information provided on the natural
product pages is only a guideline based on current literature and the pharmacological
action of these products. It should not be used as the sole source of information on
these products. Many of the drug interactions listed are not found in current
literature but are based on likely interactions due to the actions of the interacting
drugs. It is recommended that a qualified and licensed healthcare professional be
consulted for additional information. Although the information provided is from
reliable sources, Solumedia has no liability. This information is provided only as a
service.
This page was last updated on 04/29/05. |